The crystal structure is shown in the gure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Source of material
The mixture of 2-(4-hydroxy-3-methoxybenzylidene)-2,3-dihydroinden-1-one (21 mmol), paraformaldehyde (25 mmol) 
Experimental details
H atom were placed in calculated positions with O-H = 0.82 Å, C-H = 0.93-0.96 Å, and re ned using a riding model with U iso (H) = 1.2Ueq(C) for the aromatic and methylene H atoms and U iso (H) = 1.5Ueq(C,O) for the methyl and hydroxyl H atoms.
Discussion
Mannich bases have several biological activities such as antimicrobial [2] , antifungal [3] , anticonvulsant [4] , antiin ammatory [5] , and cytotoxic/anticancer [6, 7] activities. The title Mannich base, 2-[4-hydroxy-5-methoxy-3-(4-methylpiperazin-1-ylmethyl)-benzylidene]-indan-1-one (cf. the gure) can be concluded from the gure was synthesized starting from 2-(4-hydroxy-3-methoxybenzylidene)-indan-1-one, and was tested as inhibitors of the zinc metalloenzyme cytosolic human carbonic anhydrase (hCA I, and II) isoforms. The title compound is a strong hCA I (Ki: 484.02 ± 30.30 nM) and II inhibitor (Ki: 526.30 ± 112.9 nM).
In the title compound, the piperazine ring (N1/N2/C19-C22) adopts a chair conformation with the puckering parameters [8] of Q T = 0.5697(19) Å, θ = 0.0(2)°and φ = 82(12)°, respectively. The 2,3-dihydro-1H-indene ring system (C1-C9) is essentially planar [the puckering parameters are Q(2) = 0.007(2) Å and φ(2) = 20(16)°] and its mean plane makes a dihedral angle of 9.27(7)°with the central benzene ring (C11-C16). The intramolecular O3-H3O· · · N1 hydrogen bonds stabilizes the molecular conformation of the title compound. In the crystal, molecules are linked by weak C-H· · · O, C-H· · · N and C-H· · · π interactions.
